(Q38880023)

7 September 2017

title

Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda (English)

1 reference

7 September 2017

0 references

0 references

0 references

1 reference

1

1 reference

7 September 2017

14

Narcis B Kabatereine

1 reference

7 September 2017

Mark Booth

3

0 references

Birgitte J Vennervald

2

object named as

Birgitte J Vennervald

1 reference

7 September 2017

9

Joseph K Mwatha

1 reference

7 September 2017

10

Gachuhi Kimani

1 reference

7 September 2017

13

Edridah Tukahebwa

1 reference

7 September 2017

Sarah Joseph

4

1 reference

7 September 2017

Colin M Fitzsimmons

5

1 reference

7 September 2017

Pierre Cahen

6

1 reference

7 September 2017

Robert F Sturrock

7

1 reference

7 September 2017

John H Ouma

8

1 reference

7 September 2017

H Curtis Kariuki

11

1 reference

7 September 2017

Francis Kazibwe

12

1 reference

7 September 2017

publication date

15 December 2005

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

7 September 2017

published in

1 reference

7 September 2017

volume

100

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

216-223

1 reference

Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Pathological lesions associated with Schistosoma mansoni infection in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Cytokine Regulation of Periportal Fibrosis in Humans Infected with Schistosoma mansoni: IFN- Is Associated with Protection Against Fibrosis and TNF- with Aggravation of Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda II. Hospital investigation of a sample from the Panyagoro community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.03.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2005.03.016

1 reference

7 September 2017

1 reference